Inhibition of Proteinase K Activity by Copper(II) Ions,
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Disease-related prion protein, PrPSc, can be distinguished from its normal cellular precursor, PrPC, by its detergent insolubility and partial resistance to proteolysis. Several studies have suggested that copper(II) ions can convert PrPC to a proteinase K-resistant conformation; however, interpretation of these studies is complicated by potential inhibition of proteinase K (PK) by copper(II) ions. Here we have examined directly the kinetic and equilibrium effects of copper(II) ions on PK activity using a simple synthetic substrate, p-nitrophenyl acetate. We show that at equilibrium two to three copper(II) ions bind stoichiometrically to PK and destroy its activity (Kd < 1 microM). This inhibition has two components, an initial reversible and weak binding phase and a slower, irreversible abolition of activity with a half-time of 6 min at saturating copper(II) ion concentrations. Copper(II) ions produce a similar biphasic inhibition of PK activity in the presence of brain homogenate but only when the copper(II) ion concentration exceeds that of the chelating components present in brain tissue. Under these conditions, the apparent resistance of PrPC to proteolysis by PK appears to be directly attributable to the inhibition of PK activity by copper(II) ions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Creatine has been shown to increase the sprint capacity when performing repeated sprints [83].”
From Periodized Nutrition for Athletes (2017) · cites this paper as [83]
Citations
Cites
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Self-citationNature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161 · cited 1×
“According to the protein-only hypothesis ( 4 ), an abnormal PrP isoform is the principal, if not sole, component of the transmissible prion, with prion propagation occurring through PrPSc acting to replicate itself with high fidelity by recruiting endogenous PrPC (1, 2). The formation of PrPSc from PrPC is associated…”
BackgroundMouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M., & Diringer, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.12.3688-3693.1987 · Cited by 766
Wadsworth, J., Joiner, S., Hill, A., Campbell, T., Desbruslais, M., Luthert, P., & Collinge, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05403-4 · Cited by 693
Self-citationConsequences of manganese replacement of copper for prion protein function and proteinase resistance
Brown, D. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1180 · Cited by 269 · cited 1×
“Central to the work described here, the role of copper(II) ions in the conversion of PrP C to PrPSc and in the pathogenesis of prion diseases has generated much interest (5-12).”
BackgroundCopper(II) Inhibits in Vitro Conversion of Prion Protein into Amyloid Fibrils
Bocharova, O. V., Breydo, L., Salnikov, V. V., & Baskakov, I. V. (2005) · Biochemistry · doi:10.1021/bi050251q · Cited by 171
Molecular and clinical classification of human prion disease
Wadsworth, J. D. F., Hill, A. F., Beck, J. A., & Collinge, J. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.241 · Cited by 155
Self-citationCopper(II)-induced Conformational Changes and Protease Resistance in Recombinant and Cellular PrP
Qin, K., Yang, D.-S., Yang, Y., Chishti, M. A., Meng, L.-J., Kretzschmar, H. A., Yip, C. M., Fraser, P. E., & Westaway, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.25.19121 · Cited by 153 · cited 1×
“Central to the work described here, the role of copper(II) ions in the conversion of PrP C to PrPSc and in the pathogenesis of prion diseases has generated much interest (5-12).”
BackgroundReversibility of Scrapie Inactivation Is Enhanced by Copper
McKenzie, D., Bartz, J., Mirwald, J., Olander, D., Marsh, R., & Aiken, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25545 · Cited by 134
Kim, N.-H., Choi, J.-K., Jeong, B.-H., Kim, J.-I., Kwon, M.-S., Carp, R. I., & Kim, Y.-S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2117fje · Cited by 61 · cited 1×
“Central to the work described here, the role of copper(II) ions in the conversion of PrP C to PrPSc and in the pathogenesis of prion diseases has generated much interest (5-12).”
Background
Research works printed but not linked: 18
- Prusiner S. B., 1998, Proc. Natl. Acad. Sci. U.S.A. 95
- Collinge J., Annu. Rev. Neurosci. 24, 519−550.
- Wadsworth J. D., 2003, Bull. 66, 241−254.
- Griffith J. S., 1967, Nature 215, 1043−1044.
- McKenzie D., 1998, J. Biol. Chem. 273, 25545−25547.
- Qin K., 1912, Effect of protein age and deamidation, J. Biol. Chem. 275, 1, 19131
- Brown D. R., 2000, EMBO J. 19, 1180−1186.
- Wong B. S., 2000, Biochem. Biophys. Res. Commun. 276, 1217−1224.
- Kuczius T., 2004, Biol. Chem. 385, 739−747.
- Nishina K., 2004, J. Biol. Chem. 279, 40788−40794.
- Kim N. H., 2005, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres, FASEB J. 19, 783−785.
- Bocharova O. V., 2005, Biochemistry 44, 6776−6787.
- Muller A., 1993, J. Biol. Chem. 268, 26150−26154.
- Saxena A. K., 1996, Proteins 25, 195−201.
- Kascsak R. J., 1987, J. Virol. 61, 3688−3693.
- Wadsworth J. D. F., 2001, Lancet 358, 171−180.
- Müller A., 1994, J. Biol. Chem. 269, 23108−23111.
- Abbreviations NA, p-nitrophenyl acetate
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Creatine supplementation with specific view to exercise/sports performance: An update
Cooper, R., Naclerio, F., Allgrove, J., & Jimenez, A. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-33 · Cited by 306
Periodized Nutrition for Athletes
Jeukendrup, A. E. (2017) · Sports Medicine · doi:10.1007/s40279-017-0694-2 · Cited by 299
In sickness and in health: the widespread application of creatine supplementation
Gualano, B., Roschel, H., Lancha, A. H., Brightbill, C. E., & Rawson, E. S. (2012) · Amino Acids · doi:10.1007/s00726-011-1132-7 · Cited by 172
Nutritional Support for Exercise-Induced Injuries
Tipton, K. D. (2015) · Sports Medicine · doi:10.1007/s40279-015-0398-4 · Cited by 147
Hosseini-Koupaei, M., Shareghi, B., Saboury, A. A., Davar, F., Semnani, A., & Evini, M. (2016) · RSC Advances · doi:10.1039/c5ra24862k · Cited by 94
Hosseini-Koupaei, M., Shareghi, B., Saboury, A. A., Davar, F., Sirotkin, V. A., Hosseini-Koupaei, M. H., & Enteshari, Z. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.001 · Cited by 82
Bloomer, R. J., Farney, T. M., Trepanowski, J. F., McCarthy, C. G., Canale, R. E., & Schilling, B. K. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-16 · Cited by 56
Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity
Yen, C., Harischandra, D. S., Kanthasamy, A. G., & Sivasankar, S. (2016) · Science Advances · doi:10.1126/sciadv.1600014 · Cited by 58
Cornelissen, V., Defoor, J., Stevens, A., Schepers, D., Hespel, P., Decramer, M., Mortelmans, L., Dobbels, F., Vanhaecke, J., Fagard, R., et al. (2010) · Clinical Rehabilitation · doi:10.1177/0269215510367995 · Cited by 51
Luo, M., Di, J., Li, L., Tu, Y., & Yan, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.047 · Cited by 50
Creatine and Creatine Kinase in Health and Disease – A Bright Future Ahead?
Wyss, M., Braissant, O., Pischel, I., Salomons, G. S., Schulze, A., Stockler, S., & Wallimann, T. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_16 · Cited by 46
Hosseini-Koupaei, M., Shareghi, B., Saboury, A. A., & Davar, F. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.038 · Cited by 45
Nutrition for Acute Exercise-Induced Injuries
Tipton, K. D. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000322703 · Cited by 48
Portuguese Football Federation consensus statement 2020: nutrition and performance in football
Abreu, R., Figueiredo, P., Beckert, P., Marques, J. P., Amorim, S., Caetano, C., Carvalho, P., Sá, C., Cotovio, R., Cruz, J., et al. (2021) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2021-001082 · Cited by 38
Piscopo, M., Trifuoggi, M., Scarano, C., Gori, C., Giarra, A., & Febbraio, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-25784-z · Cited by 38
Introduction – Creatine: Cheap Ergogenic Supplement with Great Potential for Health and Disease
Wallimann, T. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_1 · Cited by 40
Performance-enhancing sports supplements: Role in critical care
Weitzel, L.-R. B., Sandoval, P. A., Mayles, W. J., & Wischmeyer, P. E. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b6f2e6 · Cited by 31
Ligand binding promotes prion protein aggregation – role of the octapeptide repeats
Yu, S., Yin, S., Pham, N., Wong, P., Kang, S., Petersen, R. B., Li, C., & Sy, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06680.x · Cited by 26
“However, this interpretation is complicated by the recent finding that Cu2+ inhibits proteinase K activity [41].”
BackgroundPushie, M. J., & Vogel, H. J. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.139568 · Cited by 23
“Although it is clear that the OR region can become structured in response to increasing copper loads, recent evidence indicates that copper itself inhibits proteinase-K, and therefore cannot be used to infer the presence of specific structuring within PrP in this manner (51).”
BackgroundJafari, A., Shareghi, B., Hosseini-Koupaei, M., & Farhadian, S. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.171 · Cited by 22
Investigation of the Thermal Stability of Proteinase K for the Melt Processing of Poly( l -lactide)
Xu, C., Battig, A., Schartel, B., Siegel, R., Senker, J., von der Forst, I., Unverzagt, C., Agarwal, S., Möglich, A., & Greiner, A. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c01008 · Cited by 22
“− 44 Whereas N -succinyl-Phe-pNA and N -succinyl-Phe-Ala-Ala-Phe-pNA exhibited only sluggish enzymatic degradation (Figures S10 and S11), proteinase K rapidly hydrolyzed N -succinyl-Ala-Ala-Pro-Leu-pNA (Figure S12).”
BackgroundJafari, A., Shareghi, B., Farhadian, S., & Tirgir, F. (2019) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2019.01.170 · Cited by 22
Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?
Sakkas, G. K., Schambelan, M., & Mulligan, K. M. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328331de63 · Cited by 25
Copper Downregulates Neprilysin Activity Through Modulation of Neprilysin Degradation
Li, M., Sun, M., Liu, Y., Yu, J. H., Yang, H., Fan, D., & Chui, D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1218 · Cited by 17
“It has been reported that at equilibrium, two to three copper ions (II) bind stoichiometrically to proteinase K (EC 3.4.21.14) and abolish its activity [23].”
InfluentialSuhre, M. H., Hess, S., Golser, A. V., & Scheibel, T. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.09.021 · Cited by 16
Effect of enzymatic deimination on the conformation of recombinant prion protein
Young, D. S., Meersman, F., Oxley, D., Webster, J. A., Gill, A. C., Bronstein, I. B., Lowe, C. R., & Dear, D. V. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.03.013 · Cited by 14
“The fact that the untreated PrP was still sensitive to PK in the presence of copper ions either argues against the recent finding that PK activity can be inhibited by copper ions or was carried out at a concentration that was not inhibitory [44].”
BackgroundBodybuilding supplementation and tooth decay
Ali, M. S., Batley, H. A., & Ahmed, F. (2015) · BDJ · doi:10.1038/sj.bdj.2015.521 · Cited by 13
Copper ion detection using novel silver nanoclusters stabilized with amido black 10B
Ma, F., Liang, S., Peng, Y., Kuang, Y., Zhang, X., Chen, S., Long, Y., & Zeng, R. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9392-4 · Cited by 12
Mishra, S., Panigrahi, B., Singh, R. K., & Mandal, D. (2022) · Catalysis Letters · doi:10.1007/s10562-022-04095-z · Cited by 12
“Hydrolysis of this substrate produces p-nitrophenol which can be easily monitored spectrophotometrically by measuring the absorbance at 405 nm [45].”
BackgroundHosseini-Koupaei, M., Shareghi, B., & Saboury, A. A. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.01.111 · Cited by 11
Daude, N., Lau, A., Vanni, I., Kang, S., Castle, A. R., Wohlgemuth, S. L., Dorosh, L., Wille, H., Stepanova, M., & Westaway, D. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101770 · Cited by 7
“This experiment, as well as the procedure for sample processing that includes a pellet-washing step and resuspension in a different buffer before the PK digestion, excludes trivial effects that could derive from inhibition of the in vitro PK digestion reaction (41).”
MethodKinetic investigation of myeloperoxidase upon interaction with copper, cadmium, and lead ions.
Shabani, M., Ani, M., Movahedian, A., & Shariat, S. Z. A. S. (2011) · Europe PMC (PubMed Central) · Cited by 4
The modifier action of NiO nanoparticles on the activity, structure, and stability of proteinase K
Jafari, A., Shareghi, B., Hosseini-Koupaei, M., & Farhadian, S. (2020) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-020-02552-2 · Cited by 3
Amorim, S., Gomes, H., & Teixeira, V. H. (2017) · Springer eBooks · doi:10.1007/978-3-662-53924-8_53 · Cited by 1
Pata, R. W., Leigh, A., Hadtke, B., Diem, G., Feinn, R., & White, D. A. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231200848 · Cited by 1
pH modulation of fibril dissociation and copper binding properties of the prion protein
Qi, X. (2012) · ScholarWorks at University of Montana
Li, L., Li, X., Xiang, M., Harbige, L. S., & Ai, H. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110001126
Kollalpitiya, K. Y. (2011) · Holmes Museum Of Anthropology (Wichita State University)
Dietary Protein Efficacy: Dose and Peri-Exercise Timing
Cotter, J. A., & Barr, D. (2012) · CRC Press eBooks · doi:10.1201/b11928-5
Nitrogenous Compounds and Supplements
Landis, J. A., Ziegenfuss, T. N., & Lopez, H. L. (2012) · CRC Press eBooks · doi:10.1201/b11928-10
Hayes, B., Zuelzke, M., Smith, A. M., Edmonson, B., Osula, D. O., Clanton, N. A., Hollingsworth, H., Chooback, L., Lockart, M. M., & Johnson, C. M. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110607
Metadata
- Authors
- Stone, L. A., Jackson, G. S., Collinge, J., Wadsworth, J. D. F., & Clarke, A. R.
- Affiliations
- MRC Prion Unit (GB)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-12-13
- Volume
- 46
- Issue
- 1
- Pages
- 245-252
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1987403976
- Cited by
- 43
- References
- 16
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 2 · 2012: 4
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- proteinase K, copper(II) ions, enzyme inhibition, prion protein, PrPSc, cellular prion protein, protease resistance, p-nitrophenyl acetate, copper binding, irreversible inhibition, brain homogenate, prion conversion
- MeSH terms
- Animals, Brain, Copper, Dose-Response Relationship, Drug, Cricetinae, Hydrogen-Ion Concentration, Kinetics, Time Factors, PrPSc Proteins, PrPC Proteins, Endopeptidase K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.